Results 21 to 30 of about 3,038,457 (311)

Formation of a type 1 diabetes young adult patient and public involvement panel to develop a health behaviour change intervention: the D1 Now study

Research Involvement and Engagement, 2017
Plain English summary Many young adults with type 1 diabetes (T1D) find it hard to control their blood glucose levels. With lots of things going on in their lives, their diabetes is often not the most important thing to them.
Mary Clare O’Hara, Áine Cunningham, Cameron Keighron, Gary Allen, Antony Caulfield, Ciara Duffy, Michelle Long, Madeleine Mallon, Monica Mullins, Garret Tonra, Sarah Simkin, Lisa Hynes, Máire O’Donnell, Molly Byrne, Sean F Dinneen, the D1 Now Type 1 Diabetes Young Adult Study Group   +15 more
doaj   +1 more source

MXene based saturation organic vertical photoelectric transistors with low subthreshold swing

Nature Communications, 2022
The modulation of Schottky barrier, which dominates the carrier injection in vertical organic field-effect transistors, strongly depends on the source electrode. Here, Chen et al.
Enlong Li, Changsong Gao, Rengjian Yu, Xiumei Wang, Lihua He, Yuanyuan Hu, Huajie Chen, Huipeng Chen, Tailiang Guo   +8 more
doaj   +1 more source

Apportioning Culpability in Multiple Perpetrator Acts of Terrorism

Arab Journal of Forensic Sciences & Forensic Medicine, 2017
The Depravity Standard instrument was developed to operationalize depraved elements of crimes. It consists of 25items that were derived using multiple sources of data, including case reviews, input from professionals, and over 40,000 survey respondents ...
Kate Y. O’Malley, James D. Seward, Michael Welner   +2 more
doaj   +1 more source

The Importance of Cost Structure for the Effectiveness of State Aid

Wirtschaftsdienst, 2021
For many firms, the coronavirus crisis has lead to persistent sales slumps that generated urgent liquidity demand — unless fixed costs were reduced. The authors use a newly developed classification procedure that makes the cost structure of companies and,
Jannis Bischof, Christopher Karlsson, Davud Rostam-Afschar, Thomas Simon   +3 more
doaj   +1 more source

Stable Semi-Transparent Dye-Sensitized Solar Modules and Panels for Greenhouse Application

Energies, 2021
Our world is facing an environmental crisis that is driving scientists to research green and smart solutions in terms of the use of renewable energy sources and low polluting technologies.
Jessica Barichello, Luigi Vesce, Paolo Mariani, Enrico Leonardi, Roberto Braglia, Aldo Di Carlo, Antonella Canini, Andrea Reale   +7 more
doaj   +1 more source

Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020

Scientific Reports, 2022
Pre-vaccine SARS-CoV-2 seroprevalence data from Germany are scarce outside hotspots, and socioeconomic disparities remained largely unexplored. The nationwide representative RKI-SOEP study (15,122 participants, 18–99 years, 54% women) investigated ...
Hannelore Neuhauser, Angelika Schaffrath Rosario, Hans Butschalowsky, Sebastian Haller, Jens Hoebel, Janine Michel, Andreas Nitsche, Christina Poethko-Müller, Franziska Prütz, Martin Schlaud, Hans W. Steinhauer, Hendrik Wilking, Lothar H. Wieler, Lars Schaade, Stefan Liebig, Antje Gößwald, Markus M. Grabka, Sabine Zinn, Thomas Ziese   +18 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Experiences of patients and public partners in codesign of Lynch Choices™: an evaluation study using the Patient Engagement In Research Scale (PEIRS-22)

Research Involvement and Engagement
Background Patient and public involvement and engagement (PPIE) in health research aims to make research more relevant, clear and useful to deliver results that matter most to people. PPIE can be valuable but it is not always easy.
Kelly Kohut, Lesley Turner, Caroline Dale, Sue Duncombe, Rochelle Gold, Sonia Patton, Richard Stephens, Frankie Vale, Helen White, Steve Worrall, Julie Young, Tracy Smith, Roberta Horgan, Kate Morton, Becky Foster, the CanGene-CanVar Patient Reference Panel, the International Lynch Decision Aid Expert Partner Panel, Diana Eccles, Claire Foster   +18 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source